Condensed Balance Sheets - USD ($)	Apr. 30, 2025	Jul. 31, 2024
Current assets
Cash and cash equivalents	$ 1,768	$ 1,845
Accounts receivable
Prepayment (including $20,000 and $0 of consulting services from related parties as of April 30, 2025 and April 30, 2024 respectively)	26,368	10,912
Total current assets	28,136	12,757
Non - current asset
Plant and equipment, net		137
Total non - current asset		137
TOTAL ASSETS	28,136	12,894
Current liabilities
Accrued liabilities	2,500	5,410
Other payable		7,780
Total current liabilities	2,500	13,190
Total liabilities	2,500	13,190
Stockholders’ equity
Common stock – Par value $ 0.001; Authorized: 75,000,000 shares; Issued and outstanding: 6,720,000 and 5,760,000 shares as of April 30, 2025 and July 31, 2024, respectively	6,720	5,760
Additional paid in capital	82,845	51,840
Accumulated deficit	(63,929)	(57,896)
Total stockholders’ equity	25,636	(296)
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY	$ 28,136	$ 12,894